-
2
-
-
0026735778
-
Mechanisms of multidrug resistance in cancer treatment
-
Harris AL, Hochhauser D . Mechanisms of multidrug resistance in cancer treatment . Acta Oncol 1992; 31: 205- 213.
-
(1992)
Acta Oncol
, vol.31
, pp. 205-213
-
-
Harris, A.L.1
Hochhauser, D.2
-
3
-
-
77958099641
-
Multiple drug resistance mechanisms in cancer
-
Baguley BC . Multiple drug resistance mechanisms in cancer . Mol Biotechnol 2010; 46 : 308 - 316.
-
(2010)
Mol Biotechnol
, Issue.46
, pp. 308-316
-
-
Baguley, B.C.1
-
4
-
-
73649139235
-
Side population and cancer stem cells: Therapeutic implications
-
Moserle L, Ghisi M, Amadori A, et al . Side population and cancer stem cells: Therapeutic implications . Cancer Lett 2010; 288: 1- 9.
-
(2010)
Cancer Lett
, Issue.288
, pp. 1-9
-
-
Moserle, L.1
Ghisi, M.2
Amadori, A.3
-
5
-
-
84862260770
-
Arare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential
-
Lee CG, Das B, Lin TL, et al . A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential. Br J Haematol 2012; 158: 79- 90.
-
(2012)
Br J Haematol
, Issue.158
, pp. 79-90
-
-
Lee, C.G.1
Das, B.2
Lin, T.L.3
-
6
-
-
77955125866
-
Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination
-
Vega F, Davuluri Y, Cho-Vega JH, et al . Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination . J Cell Mol Med 2010; 14 : 1532 - 1545.
-
(2010)
J Cell Mol Med
, Issue.14
, pp. 1532-1545
-
-
Vega, F.1
Davuluri, Y.2
Cho-Vega, J.H.3
-
7
-
-
33750302541
-
SP analysis may be used to identify cancer stem cell populations
-
Hadnagy A, Gaboury L, Beaulieu R, Balicki D . SP analysis may be used to identify cancer stem cell populations . Exp Cell Res 2006; 312 : 3701 - 3710.
-
(2006)
Exp Cell Res
, vol.312
, pp. 3701-3710
-
-
Hadnagy, A.1
Gaboury, L.2
Beaulieu, R.3
Balicki, D.4
-
8
-
-
48349133869
-
Side population cells in human cancers
-
Wu C, Alman BA . Side population cells in human cancers . Cancer Lett 2008; 268: 1- 9.
-
(2008)
Cancer Lett
, vol.268
, pp. 1-9
-
-
Wu, C.1
Alman, B.A.2
-
9
-
-
77349125572
-
Characterization of a stem-like population in hepatocellular carcinoma MHCC97 cells
-
Z hang N, L i R, T ao K S, et a l. C haracterization of a stem-like population in hepatocellular carcinoma MHCC97 cells . Oncol Rep 2010; 23 : 827 - 831.
-
(2010)
Oncol Rep
, Issue.23
, pp. 827-831
-
-
Zhang, N.1
Li, R.2
Tao K, S.3
-
10
-
-
0025164639
-
Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment
-
MacEwen EG . Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment . Cancer Metastasis Rev 1990; 9 : 125 - 136.
-
(1990)
Cancer Metastasis Rev
, vol.9
, pp. 125-136
-
-
MacEwen, E.G.1
-
11
-
-
0033671255
-
Spontaneously occurring tumors of companion animals as models for human cancer
-
Vail DM, MacEwen EG . Spontaneously occurring tumors of companion animals as models for human cancer . Cancer Invest 2000; 18 : 781 - 792.
-
(2000)
Cancer Invest
, vol.18
, pp. 781-792
-
-
Vail, D.M.1
MacEwen, E.G.2
-
12
-
-
80051988805
-
Identifi cation of cancer stem cells derived from a canine lung adenocarcinoma cell line
-
Nemoto Y, Maruo T, Sato T, et al . Identifi cation of cancer stem cells derived from a canine lung adenocarcinoma cell line . Vet Pathol 2011; 48 : 1029 - 1034.
-
(2011)
Vet Pathol
, Issue.48
, pp. 1029-1034
-
-
Nemoto, Y.1
Maruo, T.2
Sato, T.3
-
13
-
-
82555201372
-
Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature
-
Ferletta M, Grawe J, Hellmen E . Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature . Int J Dev Biol 2011; 55: 791- 799.
-
(2011)
Int J Dev Biol
, Issue.55
, pp. 791-799
-
-
Ferletta, M.1
Grawe, J.2
Hellmen, E.3
-
14
-
-
56149083521
-
Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using realtime polymerase chain reaction
-
Y amazaki J, B aba K, G oto-Koshino Y, et a l. Q uantitative assessment of minimal residual disease (MRD) in canine lymphoma by using realtime polymerase chain reaction . Vet Immunol Immunopathol 2008; 126 : 321 - 331.
-
(2008)
Vet Immunol Immunopathol
, vol.126
, pp. 321-331
-
-
Yamazaki, J.1
Baba, K.2
Goto-Koshino, Y.3
-
15
-
-
68849128750
-
Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines
-
Hiraoka H, Minami K, Kaneko N, et al . Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines . J Vet Med Sci 2009; 71 : 769 - 777.
-
(2009)
J Vet Med Sci
, vol.71
, pp. 769-777
-
-
Hiraoka, H.1
Minami, K.2
Kaneko, N.3
-
16
-
-
62549131208
-
The Dog Liver Contains A " side population " of cells with hepatic progenitor-like characteristics
-
Arends B, Vankelecom H, Vander Borght S, et al . The dog liver contains a " side population " of cells with hepatic progenitor-like characteristics . Stem Cells Dev 2009; 18 : 343 - 350.
-
(2009)
Stem Cells Dev
, vol.18
, pp. 343-350
-
-
Arends, B.1
Vankelecom, H.2
Vander Borght, S.3
-
17
-
-
33745852782
-
Modulation of multidrug resistance effl ux pump activity to overcome chemoresistance in cancer
-
Modok S, Mellor HR, Callaghan R . Modulation of multidrug resistance effl ux pump activity to overcome chemoresistance in cancer. Curr Opin Pharmacol 2006; 6: 350- 354.
-
(2006)
Curr Opin Pharmacol
, vol.6
, pp. 350-354
-
-
Modok, S.1
Mellor, H.R.2
Callaghan, R.3
-
18
-
-
80053211502
-
Development of imatinib and dasatinib resistance: Dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1
-
1980-1990
-
Gromicho M, Dinis J, Magalhaes M, et al . Development of imatinib and dasatinib resistance: Dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1 . Leuk Lymphoma 2011; 52 : 1980 - 1990.
-
(2011)
Leuk Lymphoma
, pp. 52
-
-
Gromicho, M.1
Dinis, J.2
Magalhaes, M.3
-
19
-
-
77958484000
-
Quantitative analysis of mRNA for 10 diff erent drug resistance factors in dogs with lymphoma
-
Tomiyasu H, Goto-Koshino Y, Takahashi M, et al . Quantitative analysis of mRNA for 10 diff erent drug resistance factors in dogs with lymphoma . J Vet Med Sci 2010; 72: 1165- 1172.
-
(2010)
J Vet Med Sci
, Issue.72
, pp. 1165-1172
-
-
Tomiyasu, H.1
Goto-Koshino, Y.2
Takahashi, M.3
-
20
-
-
0034807617
-
Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway
-
Y ang J M, V assil A D, H ait W N. A ctivation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway. Mol Pharmacol 2001; 60: 674- 680.
-
(2001)
Mol Pharmacol
, vol.60
, pp. 674-680
-
-
Yang, J.M.1
Vassil, A.D.2
Hait, W.N.3
-
21
-
-
79960929532
-
Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines
-
Z hang Z, K noepp S M, K u H, et a l. Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines. Clin Exp Metastasis 2011; 28 : 551 - 565.
-
(2011)
Clin Exp Metastasis
, Issue.28
, pp. 551-565
-
-
Zhang, Z.1
Knoepp S, M.2
Ku, H.3
-
22
-
-
65649095142
-
Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion
-
Kabashima A, Higuchi H, Takaishi H, et al . Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion . Int J Cancer 2009; 124 : 2771 - 2779.
-
(2009)
Int J Cancer
, vol.124
, pp. 2771-2779
-
-
Kabashima, A.1
Higuchi, H.2
Takaishi, H.3
-
23
-
-
38849139125
-
ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition
-
Yin L, Castagnino P, Assoian RK . ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition . Cancer Res 2008; 68 : 800 - 807.
-
(2008)
Cancer Res
, vol.68
, pp. 800-807
-
-
Yin, L.1
Castagnino, P.2
Assoian, R.K.3
-
24
-
-
0033564958
-
Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia
-
Hu XF, Slater A, Kantharidis P, et al . Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia . Blood 1999; 93 : 4086 - 4095.
-
(1999)
Blood
, vol.93
, pp. 4086-4095
-
-
Hu, X.F.1
Slater, A.2
Kantharidis, P.3
-
25
-
-
0021143707
-
The genetic origin of drug resistance in neoplasms: Implications for systemic therapy
-
Goldie JH, Coldman AJ . The genetic origin of drug resistance in neoplasms: Implications for systemic therapy . Cancer Res 1984; 44 : 3643 - 3653.
-
(1984)
Cancer Res
, vol.44
, pp. 3643-3653
-
-
Goldie, J.H.1
Coldman, A.J.2
-
26
-
-
9144266455
-
Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia
-
V alera E T, S crideli C A, Q ueiroz R G, et a l. M ultiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia . Sao Paulo Med J 2004; 122: 166- 171.
-
(2004)
Sao Paulo Med J
, vol.122
, pp. 166-171
-
-
Valera E, T.1
Scrideli C, A.2
Queiroz, R.G.3
-
27
-
-
34250306257
-
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells
-
Ho MM, Ng AV, Lam S, et al . Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67: 4827- 4833.
-
(2007)
Cancer Res
, vol.67
, pp. 4827-4833
-
-
Ho, M.M.1
Ng, A.V.2
Lam, S.3
-
28
-
-
79955137781
-
Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma
-
S hen H, X u W, L uo W, et a l. U pregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma . Exp Hematol 2011; 39 : 558 - 569.
-
(2011)
Exp Hematol
, Issue.39
, pp. 558-569
-
-
Shen, H.1
Xu, W.2
Luo, W.3
|